Search - tctmd.com

Displaying 941 - 960 of 2261

Sort: Relevancy | Date

Presentation TCT Abstracts Posters 2018

Investigation of Potential Predictors of Irregular Protrusion following Cobalt Chromium Everolimus-Eluting Stent Implantation in Patients with Stable Coronary Artery Disease : Subanalysis of the MECHANISM-Elective study

Presenter: Yuya Taguchi

September 25, 2018

Presentation TCT Abstracts Posters 2018

Increased Risk of Acute Stent Thrombosis Associated with Synergy® Bioabsorbable Polymer-Coated Drug-Eluting Stent after Percutaneous Coronary Intervention for Acute Coronary Syndrome

Presenter: Joel Lardizabal

September 25, 2018

Presentation TCT Abstracts Posters 2018

Randomized comparison of an everolimus-eluting bioresorbable scaffold versus everolimus-eluting metallic stent in primary percutaneous coronary intervention of ST-segment elevation myocardial infarction

Presenter: Omeed Neghabat

September 25, 2018

Presentation TCT Abstracts Posters 2018

Clinical Outcomes of Patients Undergoing Novolimus-eluting Bioresorbable Scaffolds

Presenter: Cigdem Koca Tari

September 25, 2018

Presentation TCT 2018

ABSORB IV: A Blinded Randomized Trial of a Polymeric Everolimus-Eluting Bioresorbable Scaffold in an Expanded Patient Population Using Optimized Technique

Presenter: Felix Mahfoud, Patrick W. Serruys, Gregg W. Stone

September 25, 2018

Presentation TCT 2018

MAIN-COMPARE: Ten-Year Follow-up From a Nonrandomized Trial of Drug-Eluting Stents vs Bypass Surgery in Patients With Left Main Disease

Presenter: Jeroen J. Bax, Seung-Jung Park

September 24, 2018

Presentation TCT 2018

SYNTAXES: Ten-Year Follow-up From a Randomized Trial of Drug-Eluting Stents vs Bypass Surgery in Patients With Left Main and Triple Vessel Disease (Preliminary Results)

Presenter: Jeroen J. Bax, Daniel J.F.M. Thuijs

September 24, 2018

Presentation TCT 2018

PREPARE-CALC: A Randomized Trial of High-speed Rotational Atherectomy Prior to Drug-Eluting Stent Implantation in Severely Calcified Coronary Lesions

Presenter: Jeroen J. Bax, Gert Richardt

September 24, 2018

News Opinion Editor's Corner TCT 2018

TCT 2018, Day Three: Intravascular Imaging and Anticoagulation

Shelley Wood

September 24, 2018

Presentation TCT 2018

ULTIMATE: A Randomized Trial of Intravascular Ultrasound Guidance of Coronary Drug-Eluting Stent Implantation in an All-Comers Patient Population

Presenter: Gregg W. Stone, Junjie Zhang

September 24, 2018

Presentation TCT 2018

FDA Perspectives on DCB in Coronary and Peripheral Interventions

Presenter: Juan F. Granada, Bruno Scheller, P.F. Adrian Magee

September 23, 2018

Presentation TCT 2018

DCB for Coronary Artery Disease: In-Stent Restenosis, NSTEMI, and Small Vessels

Presenter: Juan F. Granada, Bruno Scheller

September 23, 2018

Presentation TCT 2018

DCB for BTK: Clinical Challenges and Lessons Learned

Presenter: Juan F. Granada, Bruno Scheller, Sahil A. Parikh

September 23, 2018

Presentation TCT 2018

Periprocedural Management of Anticoagulation in Patients With Nonvalvular Atrial Fibrillation

Presenter: Davide Capodanno, Giulio Stefanini, Robert A. Byrne

September 23, 2018

Presentation TCT 2018

US and ESC Guidelines and Consensus on Antithrombotic Therapy in Patients With Atrial Fibrillation Undergoing PCI

Presenter: Davide Capodanno, Giulio Stefanini, Dominick J. Angiolillo

September 23, 2018

Presentation TCT 2018

In 2018 When Is Warfarin Therapy Required vs Acceptable, and How Should it Be Dosed After PCI?

Presenter: Davide Capodanno, Giulio Stefanini, Freek W.A. Verheugt

September 23, 2018

Presentation TCT 2018

Has PIONEER and REDUAL Changed My Practice? What Are the Outstanding Issues?

Presenter: Davide Capodanno, Giulio Stefanini, C. Michael Gibson

September 23, 2018

Presentation TCT 2018

Pharmacotherapy Challenges and Possible Solutions in the PCI Patient on Chronic Oral Anticoagulation

Presenter: Davide Capodanno, Giulio Stefanini, Tullio Palmerini

September 23, 2018

Presentation TCT 2018

SORT OUT IX: Summary and Clinical Implications

Presenter: Andreas Baumbach, Stephan Windecker, Lisette Okkels Jensen

September 23, 2018

Presentation TCT 2018

LEADERS FREE II: Summary and Clinical Implications

Presenter: Andreas Baumbach, Stephan Windecker, Mitchell W. Krucoff

September 23, 2018

Advertisement

Investigation of Potential Predictors of Irregular Protrusion following Cobalt Chromium Everolimus-Eluting Stent Implantation in Patients with Stable Coronary Artery Disease : Subanalysis of the MECHANISM-Elective study

Increased Risk of Acute Stent Thrombosis Associated with Synergy® Bioabsorbable Polymer-Coated Drug-Eluting Stent after Percutaneous Coronary Intervention for Acute Coronary Syndrome

Randomized comparison of an everolimus-eluting bioresorbable scaffold versus everolimus-eluting metallic stent in primary percutaneous coronary intervention of ST-segment elevation myocardial infarction

Clinical Outcomes of Patients Undergoing Novolimus-eluting Bioresorbable Scaffolds

ABSORB IV: A Blinded Randomized Trial of a Polymeric Everolimus-Eluting Bioresorbable Scaffold in an Expanded Patient Population Using Optimized Technique

MAIN-COMPARE: Ten-Year Follow-up From a Nonrandomized Trial of Drug-Eluting Stents vs Bypass Surgery in Patients With Left Main Disease

SYNTAXES: Ten-Year Follow-up From a Randomized Trial of Drug-Eluting Stents vs Bypass Surgery in Patients With Left Main and Triple Vessel Disease (Preliminary Results)

PREPARE-CALC: A Randomized Trial of High-speed Rotational Atherectomy Prior to Drug-Eluting Stent Implantation in Severely Calcified Coronary Lesions

TCT 2018, Day Three: Intravascular Imaging and Anticoagulation

ULTIMATE: A Randomized Trial of Intravascular Ultrasound Guidance of Coronary Drug-Eluting Stent Implantation in an All-Comers Patient Population

FDA Perspectives on DCB in Coronary and Peripheral Interventions

DCB for Coronary Artery Disease: In-Stent Restenosis, NSTEMI, and Small Vessels

DCB for BTK: Clinical Challenges and Lessons Learned

Periprocedural Management of Anticoagulation in Patients With Nonvalvular Atrial Fibrillation

US and ESC Guidelines and Consensus on Antithrombotic Therapy in Patients With Atrial Fibrillation Undergoing PCI

In 2018 When Is Warfarin Therapy Required vs Acceptable, and How Should it Be Dosed After PCI?

Has PIONEER and REDUAL Changed My Practice? What Are the Outstanding Issues?

Pharmacotherapy Challenges and Possible Solutions in the PCI Patient on Chronic Oral Anticoagulation

SORT OUT IX: Summary and Clinical Implications

LEADERS FREE II: Summary and Clinical Implications

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content